We are a pioneering healthcare company at the forefront of advancing the safe, evidence-based medical use of psychedelics and THC. Through rigorous clinical research, compassionate patient care, and uncompromising standards of safety and efficacy, we develop transformative treatments for unmet medical needs.

Guided by a patient-first philosophy, our mission is to deliver personalized, integrative therapies that improve lives while upholding the highest standards of clinical excellence, integrity, and empathy. We combine cutting-edge science with ethical innovation to expand access to novel cannabinoid and psychedelic-assisted therapies in regulated healthcare settings.

At Wyatt Group, we are committed to:

•  Conducting high-quality clinical research and trials

•  Partnering with clinicians, researchers, and healthcare institutions

•  Prioritizing patient safety, education, and long-term outcomes

We believe the future of mental health and chronic care lies in responsible, science-backed innovation. Whether you’re a healthcare professional, researcher, investor, or potential partner, we’d love to connect and explore collaboration opportunities.

Wyatt Group

Org chart

Teams

Offices

Wyatt Group

Org chart

Teams

Offices

Related companies